POST EVENT CONTENT: Maximizing the Clinical Potential of Gamma Delta T Cell-Based Therapies

Time: 6:30 pm
day: Day One


• Overview of manufacture of gene-modified gamma delta T cells
• Understanding and optimizing activation pathways in gamma delta T cells
• Optimizing the health and persistence of gamma delta T cell therapies and minimizing host versus graft responses